Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ru Cat. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
This novel alcohol-based synthesis protocol offers high yield and enhanced safety for scalable catalyst manufacturing supply chains. It enables reliable sourcing of high-purity olefin metathesis catalysts for global pharmaceutical and chemical production needs.
Patent CN114478627B reveals a novel Ru-catalyzed allylation method for biphenyl phosphine ligands, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN110520403B details a ruthenium-catalyzed route minimizing dimer impurities. This breakthrough offers cost reduction in fine chemical manufacturing and reliable supply chain continuity.
Novel 2-step route for Valemetostat intermediate. High purity, scalable process. Cost-effective supply chain solution for oncology drug manufacturing.
Patent CN101941900A reveals a novel Ru-catalyzed asymmetric hydrogenation route for high-purity chiral acids, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Patent CN105622363B enables one-step vanillyl alcohol ether production. Dual catalyst system ensures high purity and supply chain stability for global buyers.
Novel chiral spirocyclic diphosphine ligand synthesis via patent CN1562926A. High enantioselectivity (98% ee) for asymmetric hydrogenation. Cost-effective supply chain solutions.
Patent CN110922427A reveals TMSOTf-catalyzed route for sterically hindered phosphonites. Green, solvent-free process offers cost reduction in pharma intermediate manufacturing.
Patent CN102070383A details a green Ru-catalyzed oxidation of olefins to 1,2-diketones. Offers high selectivity, broad substrate scope, and cost-effective manufacturing for pharma intermediates.
Patent CN111574450A details novel chiral biphenyl catalysts enabling high-yield asymmetric alkylation with reduced costs and superior supply chain reliability for pharmaceutical intermediates.
Patent CN115215895A details a cost-effective ruthenium-catalyzed synthesis of five-membered silicon-containing fused heterocycles, offering significant supply chain advantages for pharmaceutical intermediates.
Novel catalytic method for imidazolone compounds ensures high yield and purity. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Advanced nano-ruthenium catalytic hydrogenation for high-purity DCH18C6. Superior cis-isomer selectivity for nuclear waste treatment applications.
Patent CN117535268A reveals high-purity esterase resolution. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN104710259A details a novel Ru/C catalyzed amide synthesis using air oxidation, offering high purity and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN110143935B details a novel Ru-catalyzed route to 2,5-disubstituted furans under air. This method offers mild conditions and high regioselectivity for reliable pharmaceutical intermediate supply.
Patent CN110526944A reveals high-efficiency Ru catalyst for asymmetric transfer hydrogenation, offering cost reduction and supply reliability.
Patent CN112159360B details a green ruthenium-catalyzed route for triazine derivatives, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN117003647A details a Ru-Co alloy catalyst for low-temperature reductive amination, offering high yield and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN108299482B details a novel nucleophilic route for 18F-BPA, offering higher specific activity and safer processing for PET imaging agents.